Trial · NCT02593370
Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block
NCT02593370, Phase 1, Completed, Thomas F. Bendtsen
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block. Trials, record NCT02593370. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02593370
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Suprasacral Parallel Shift - Ultrasound/MR Image Fusion Guided Lumbosacral Plexus Block
- NCT number
- NCT02593370
- Status
- Completed
- Phases
- Phase 1
- Enrollment
- 26 participants, actual
- Lead sponsor
- Thomas F. Bendtsen
- Conditions
- Hip Fractures, Anesthesia Local, Pain, Perioperative
- Interventions
- Lidocaine-epinephrine added gadoterate meglumine
- First posted
- 2015-11-02
- Last updated
- 2016-02-12
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Block success | Estimated 40 min after completed intervention. Presented 10 months after last patient last visit (LVLP). | Block success of the clinical relevant lumbosacral nerves that innervate the hip joint capsule estimated as significant motor block of the obturator nerve, the femoral nerve, and the lumbosacral trunk. Motor block is a significant proxy marker of sensory block. Motor block (muscle strength, mmHg) is assessed with a handheld dynamometer. |
| Secondary | Plasma lidocaine | Blood samples are withdrawn 0, 5, 10, 20, 40, 60, and 90 minutes after intervention. Presented 10 months after LVLP | |
| Secondary | Time for preparation | Estimated prior to intervention. Presented 10 months after LVLP | Time for preparation in seconds is defined as the time of placement of the volunteer on the bed until the end of pre-ultrasound scanning |
| Secondary | Block procedure time | Estimated during intervention. Presented 10 months after LVLP | Block procedure time in seconds is defined as the time of the placement of the ultrasound probe on the skin to until the block needle is pulled out after injection of local anesthetics |
| Secondary | Injection site | Estimated at the end of the intervention. Presented 10 months after LVLP | |
| Secondary | Block needle depth | Estimated at the end of the intervention. Presented 10 months after LVLP | |
| Secondary | Discomfort | Estimated immediately after the intervention. Presented 10 months after LVLP | Estimated on numeric rating scale 0-10 |
| Secondary | Mean arterial pressure change | Mean arterial pressure is measured prior intervention and 5 min after intervention. Presented 10 months after LVLP | |
| Secondary | Sensory (cold, warm, touch, pain) block of the dermatomes T12-S3 and the lateral femoral cutaneous nerve | Estimated 50 min after intervention. Presented 10 months after LVLP | |
| Secondary | Perineural spread of local anesthetics added gadoterate meglumine | Estimated on MRI sampled 10-30 minutes after intervention. Presented 10 months after LVLP |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 28396863 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02593370
GET https://conductscience.org/api/trials/v1/NCT02593370/registered